We are live on ! Find out more
PA

Paralel Advisors Portfolio holdings

AUM $2.59B
1-Year Est. Return 17.02%
This Fund
S&P 500
This Quarter Est. Return
+9.84%
1 Year Est. Return
+17.02%
3 Year Est. Return
+75.36%
5 Year Est. Return
10 Year Est. Return
AUM
$1.95B
AUM Growth
+$147M
Cap. Flow
-$7.1M
Cap. Flow %
-0.36%
Top 10 Hldgs %
72.06%
Holding
105
New
26
Increased
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$6.35M
2
AMT icon
American Tower
AMT
+$3.79M
3
LAMR icon
Lamar Advertising Co
LAMR
+$3.49M
4
HIW icon
Highwoods Properties
HIW
+$2.36M
5
MTN icon
Vail Resorts
MTN
+$2.26M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$45.6M
2
WMT icon
Walmart Inc
WMT
+$7.94M

Sector Composition

Rank Sector Weight
1 Financials 54.32%
2 Technology 11.97%
3 Consumer Discretionary 7.94%
4 Industrials 6.37%
5 Energy 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FR icon
101
First Industrial Realty Trust
FR
$8.21B
$646K 0.03%
+12,260
New +$571K
GLPI icon
102
Gaming and Leisure Properties
GLPI
$12.4B
$605K 0.03%
+12,260
New +$567K
FTRE icon
103
Fortrea Holdings
FTRE
$1.79B
$291K 0.01%
8,345
ESS icon
104
Essex Property Trust
ESS
$18.3B
$10.9K ﹤0.01%
+44
New +$9.71K
PFE icon
105
Pfizer
PFE
$159B
-1,375,000
Closed -$45.6M

Similar funds

Paralel Advisors's Q4 2023 Portfolio in Review

As of Q4 2023, Paralel Advisors held 105 positions worth $1.95B, up 8.1% from $1.81B the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Paralel Advisors's Q4 2023 filing shows 26 new, 1 reduced and 1 closed positions. Its largest new stake was Equinix: 8,271 shares worth $6.66M. The largest sale was Pfizer, an estimated $45.6M.

By sector, the portfolio is most concentrated in Financials at 54% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Paralel Advisors's largest Q4 2023 buy was Equinix: 8,271 shares worth $6.66M.
  • Paralel Advisors's biggest Q4 2023 reduction was Walmart Inc, cutting an estimated $7.94M.
  • Paralel Advisors fully exited Pfizer in Q4 2023, selling an estimated $45.6M.
  • Paralel Advisors's ten largest holdings make up 72% of its $1.95B portfolio in Q4 2023.
  • Paralel Advisors opened 26 new positions and closed 1 in Q4 2023.
  • Paralel Advisors's portfolio value rose 8.1% quarter-over-quarter to $1.95B.

Based on Paralel Advisors's 13F filing for Q4 2023, filed 12 Feb 2024.